WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
P.O.Box 4404 Nydalen
0403 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

N NERVOUS SYSTEM
N06 PSYCHOANALEPTICS

This group comprises antidepressants, psychostimulants, nootropics anti-dementia drugs and combinations with psycholeptics.

Antiobesity preparations are classified in A08 - Antiobesity preparations, excl. diet products.


N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS

Nootropics are classified in N06BX.

Clonidine and guanfacine also used in ADHD are classified in C02AC.


N06BA Centrally acting sympathomimetics

Amfetamine is classified in this group, see comment under A08AA - Centrally acting antiobesity products.

N06BC Xanthine derivatives

Caffeine in combination with respiratory stimulants is classified in R07AB.

N06BX Other psychostimulants and nootropics

This group comprises substances regarded as nootropics. Psychostimulants, which cannot be classified in the preceding groups, are also classified here.

Cyprodenate (deanol cyclohexylpropionate) is classified in N06BX04.


The DDD for idebenone is based on treatment of Lebers hereditary optic neuropathy.

Last updated: 2016-12-20